PAREA - “We need an EU-led co-production approach”

As the Biden administration establishes a federal task force to address the roll out of psychedelic medicines in the US over the next 5 years.

Europe needs to implement a similar initiative to ensure that it does not fall behind on an international level.

Previous
Previous

Second successful Phase 3 trial of MDMA-assisted therapy for PTSD

Next
Next

VJNeurology podcast with Tadeusz Hawrot